Navigation Links
Desire for Performance Coupled With Natural Ingredients Boosts Botanical Actives Consumption in Personal Care
Date:2/17/2009

-- The move from synthetic ingredients to more "natural" ingredients should be regarded as a driver for cosmetic and toiletry ingredients market. --

LITTLE FALLS, N.J., Feb. 17 /PRNewswire/ -- According to Kline & Company's study Specialty Actives and Active Delivery Systems for Personal Care 2008: U.S. and Europe, botanicals consumption is growing at 8.0%, outstripping growth of other specialty actives with average growth of 5.4%. The increased use of botanicals is one of the major changes in the cosmetics and toiletries industry in recent history.

The market for specialty actives and delivery systems in North America and Europe is approximately USD 840 million, with specialty actives in the Europe market accounting for the lions' share of the market. Botanical actives are growing in share within the specialty actives segment in both the European and U.S. markets. "Labeled" actives are showing extremely quick growth, at up to 20% a year.

A variety of plant extracts have been known for many years to confer therapeutic effects on the skin, building grounds for further development. "Today's consumer wants not only natural products, but also performance," notes Nikola Matic, senior analyst, Chemicals and Material Industry at Kline. "These two requirements were regarded as contradictory a few years ago, but highly substantiated botanical products developed recently brought new solutions to formulators."

The use of botanicals in cosmetic and toiletry formulations is strengthened by the "natural" trend. The move from synthetic ingredients to more "natural" ingredients has increased and should now be regarded as an established growth driver, which has benefited botanicals above all. Nowadays, if a synthetic product and a botanical are offering the same functionality and efficiency, the botanical active will be the formulator
'/>"/>

SOURCE Kline & Company, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Near-Wins Boost Desire to Keep Gambling
2. UNC study: Postmenopausal womens loss of sexual desire affects health, quality of life
3. Slippery slope: 1 tiny truffle can trigger desire for more treats
4. Large-Scale Survey Reveals Low Sexual Desire Most Common Distressing Female Sexual Problem, Affecting Up to One in 10 Women
5. J.D. Power and Associates Reports: A Vast Majority of Southern California Indian Gaming Casino Customers Express Desire for a Smoke-Free Environment
6. Body Image Has Little Influence on Desire for Plastic Surgery, ASPS Study Reveals
7. URAC Calls for Public Comment on Revisions to its Pharmacy Benefit Management (PBM) and Drug Therapy Management (DTM), Version 2.0 Standards and NEW Performance Measures, and PHARM Core, Version 3.0 Standards
8. Broadstreet Names Dorian Fabio Executive Vice President of Learning and Performance Improvement
9. Oxford Performance Materials Acquired By Arkema
10. Journal of American College of Surgeons study finds warm-up helps surgeons improve performance
11. Abaxis Reports Financial Performance for the Third Quarter of Fiscal 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)..., , NEW YORK, Dec. 4 Tho... than 90 offices nationwide today, to participate ...dit, tax and advisory firm,s support for literacy ...ice day reflects our firm,s long history of volunt...gathered in the spirit of caring to brighten the h...
(Date:12/4/2009)..., , SCOTTSDALE, Ariz., Dec. 4 /PRNewswire/...elf-managed, non-traded, real estate investment tr...e agreement to acquire a three building medical of...cana, Texas, and Fort Wayne, Indiana for approxima...is subject to the satisfaction of a number of cond...
(Date:12/4/2009)..., , WASHINGTON, Dec. 4 /PRNewswire-USNew...re reform would control health care costs, Leapfro...ead through example -- delivering the best quality...vels of efficiency. Thirty-four urban, eight child...09 Leapfrog Top Hospitals, based on results from T...
(Date:12/4/2009)..., Working with mice, scientists at Johns Hopkins...ave shown that a protein made by a gene called "Tw...ately distinguish stem cells that drive aggressive...r cells. , Building on recent work suggesting th...in breast tumors that drives breast cancer, scient...
(Date:12/4/2009)... Dental tourism is a phen...g for an alternative to the high price of dental w...ir search for lower priced dental care, people hav...oice as a dental tourist destination. , ...eing in business for more than 6 years, Mexican De...
Breaking Medicine News(10 mins):Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 3
... 2008 Elderly patients who use antipsychotic drug...neumonia compared to non-users. This risk is highe...creases gradually thereafter. These findings are p...and behavioral problems associated with dementia a...
... Weems, Congressman Gene Green,Among High-Level Pa... in,Health Care At U.S. News & World Report Breakf...,issued by U.S. News & World Report:, EVENT TOPIC...are, will examine the "value paradigm",between adv...
...s more than 786,000 workers, CHICAGO, April 15 T...e release of its updated statistical map entitled ...sion in 2006" that details how,many employees, bro...se employees. The data clearly shows how much the,...
...ve Workflow Tools Will Help Public Health Move Be...True Community Health Surveillance ...g Systems (HMS), (http://www.hmsinc.com ), pioneer...ools that empower epidemiologists and others in,pu...
...sults of a phase IV, open label, head-to-head stud...uency subcutaneous Rebif (interferon beta-1a) prov...lar efficacy over 18 to 30 months of continued the... and Opinion journal. , The Prospective and Retro...
...ses too much on treatments and not enough on preve...run for many women, say researchers at Michigan St...ias coverage of the disease found that over a two-...t, while only 18 percent looked at prevention. , ...
Other Medicine News:Health News:Top Policy Experts to Debate Link Between Rising Health Care Costs and Advances in Medical Technology, Wednesday, April 16, 2008, From 8:30 - 10:00 A.M., at DC's National Press Club 2Health News:Academy of General Dentistry Releases Updated Employment Statistical Map 2Health News:Health Monitoring Systems Releases EpiCenter(TM) 2Health News:Health Monitoring Systems Releases EpiCenter(TM) 3Health News:Health Monitoring Systems Releases EpiCenter(TM) 4Health News:Study shows that high-dose, high-frequency interferon produces no additional benefit 2Health News:Study finds media coverage of breast cancer focuses too little on prevention 2
(Date:12/4/2009)...NGTON, Dec. 4 Chemistr...shed by the Pharmaceutical Research and Manufactu...drugs and vaccines in development for HIV/AIDS and...hat the 97 products in development include 23 vacc...human clinical trials or awaiting approval by the ...
(Date:12/4/2009).... 4 PharmAthene, Inc. (N...medical countermeasures against biological and che... presenting results of a study demonstrating the e...thrax model in the New Zealand White (NZW) rabbit....ion at the HHS Public Health Emergency Medical Cou...
(Date:12/4/2009)...STON, Dec. 4 OrthoAccel Technologi...hich is an acceleration device to enhance orthodon...ng Education course published by PennWell Corpora... industries, including medicine and dentistry. Th...c treatment, a summary of treatment biomechanics, ...
Breaking Medicine Technology:U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 3AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 4State National Nursing Home Caregivers 3A Medicare Funding Cut to Long Term Care Will Jeopardize Vital Staffing Positions and Compromise Care for New 54470 1State National Nursing Home Caregivers 3A Medicare Funding Cut to Long Term Care Will Jeopardize Vital Staffing Positions and Compromise Care for New 54470 2State National Nursing Home Caregivers 3A Medicare Funding Cut to Long Term Care Will Jeopardize Vital Staffing Positions and Compromise Care for New 54470 3Korea Institute of Toxicology Implementing Xybion 26apos 3Bs Pristima 26amp 3B 238482 3B 13553 1Korea Institute of Toxicology Implementing Xybion 26apos 3Bs Pristima 26amp 3B 238482 3B 13553 2Patheon Announces Date of Third Quarter 2009 Financial Results Release Conference Call and Webcast 54467 1Patheon Announces Date of Third Quarter 2009 Financial Results Release Conference Call and Webcast 54467 2
...E: LLY ) has submitted a supplemental New Drug Ap...tration (FDA) seeking approval for a new,indicatio...ent of chronic,pain, the company announced today. ...ials in chronic osteoarthritis pain of the knee an...previously completed pain studies in,diabetic peri...
...ccessfully placed in three patient...May 29 Three patients with established,cardiac is... vProtect,Luminal Shield, a self-expanding intraco...y that typically occurs when stents are deployed. ...ort for the vessel to ensure that,the target coron...
Other Medicine Technology:Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration 2Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration 3Prescient Medical, Inc. Achieves Successful Clinical Debut of vProtect(TM) Luminal Shield 2
Avitene Flour
CODMAN Steerable Neuroendoscope
D185 MultiPulse Cortical Stimulator
The Wilson Plus Radiolucent Wilson Frame
Medicine Products: